This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Jennifer Snow
Founder at Apteka
Speaker

Profile

Jennifer Snow, M.P.H., is Founder of Apteka, a health policy strategy advisory firm focued on U.S. pharmaceutical policy and access. With more than 20 years of experience, she helps life sciences companies and advocacy organizations navigate complex federal and state policy landscapes and translate shifting regulations into clear, strategic action. Jennifer advises on the policy forces shaping coverage, reimbursement, pricing, and patient access across therapeutic areas including oncology, cardiovascular disease, mental health, diabetes, respiratory conditions, and rheumatoid arthritis. She is known for delivering decision-oriented insights that help organizations anticipate change, manage risk, and act with confidence.

Agenda Sessions

  • Section 4: The Evolving MFN Landscape –Implications for Access in the US and EU

    3:45pm

At this event